Position in GNPX
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$0
-$1 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
5 quarters on record
Common Shares in GNPX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Capital Advisors, Ltd. LLC holds $457,986 across 47 Biotechnology names. GNPX ranks #47 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CDXS |
Codexis, Inc.
|
28,890 | $65,291 | |
| 2 | PCVX |
Vaxcyte, Inc.
|
1,000 | $58,130 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
99 | $49,176 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
162 | $48,766 | |
| 5 | EXEL |
Exelixis, Inc.
|
731 | $39,773 | |
| 6 | VNDA |
Vanda Pharmaceuticals Inc.
|
5,000 | $30,600 | |
| 7 | CGEM |
Cullinan Therapeutics, Inc.
|
1,600 | $29,136 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
295 | $23,390 |
All Filings in GNPX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $0 | 1 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $1 | 1 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $1 | 1 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $4 | 25 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $5 | 25 | Shares | Sole | 2025-07-24 | |
| No filing history on record for this holder in this stock. | ||||||